Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members

D Turgeon, JS Carrier, E Lévesque, DW Hum… - …, 2001 - academic.oup.com
Androgens and estrogens play major roles in cell differentiation, cell growth, and peptide
secretion in steroid target tissues. In addition to the binding of these hormones to their receptors…

Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase

É Lévesque, D Turgeon, JS Carrier, V Montminy… - Biochemistry, 2001 - ACS Publications
UDP-glucuronosyltransferase (UGT) enzymes belonging to the UGT2B subfamily catalyze
the transfer of glucuronic acid to a large number of endogenous compounds, particularly …

Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues

A Bélanger, DW Hum, M Beaulieu, É Lévesque… - The Journal of steroid …, 1998 - Elsevier
Conjugation of compounds by glucuronidation is a pathway found in all vertebrates studied
to date. Although, it is widely recognized that the liver is a major site of glucuronidation, it is …

Characterization of UDP-glucuronosyltransferases active on steroid hormones

DW Hum, A Bélanger, É Lévesque, O Barbier… - The Journal of steroid …, 1999 - Elsevier
In recent years, the enzymes which are involved in the formation of DHT in steroid target
tissues have been well investigated, however, enzymes responsible for the catabolism and …

Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan …

É Lévesque, AS Bélanger, M Harvey, F Couture… - … of Pharmacology and …, 2013 - ASPET
Despite the importance of UDP-glucuronosyltransferase (UGT) 1A1*28 in irinotecan
pharmacogenetics, our capability to predict drug-induced severe toxicity remains limited. We aimed …

Pharmacogenomics of human uridine diphospho‐glucuronosyltransferases and clinical implications

C Guillemette, É Lévesque… - Clinical Pharmacology & …, 2014 - Wiley Online Library
Glucuronidation by uridine diphospho‐glucuronosyltransferase enzymes (UGTs) is a major
phase II biotransformation pathway and, complementary to phase I metabolism and …

Isolation and characterization of UGT2B15 (Y85): a UDP glucuronosyltransferase encoded by a polymorphic gene

E Levesque, M Beaulieu, MD GreeN… - Pharmacogenetics …, 1997 - journals.lww.com
polymorphisms in the genes encoding phase II drug metabolizing UDP-glucuronosyltransferases
is still undescribed, despite the many reported cases of variations in glucuronidation …

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia

…, K Fleiss, C Skrabs, É Lévesque… - Blood, The Journal …, 2013 - ashpublications.org
Uridine diphospho glucuronosyltransferase 2B17 (UGT2B17) glucuronidates androgens and
xenobiotics including certain drugs. The UGT2B17 gene shows a remarkable copy number …

Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene

É Lévesque, M Beaulieu, DW Hum… - Pharmacogenetics and …, 1999 - journals.lww.com
Variations in glucuronidation activities among different individuals have been reported;
however, genetic polymorphisms in the genes encoding phase II drug metabolizing UDP-…

Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression

É Lévesque, SP Huang, É Audet-Walsh… - Clinical Cancer …, 2013 - AACR
Purpose: Prostate cancer is a heterogeneous genetic disease, and molecular methods for
predicting prognosis in patients with aggressive form of the disease are urgently needed to …